Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Derek S ChewYanhong LiPatricia A CowperKevin J AnstromJonathan P PicciniJeanne E PooleMelanie R DanielsKristi H MonahanLinda Davidson-RayTristram D BahnsonHussein R Al-KhalidiKerry L LeeDouglas L PackerDaniel B Marknull nullPublished in: Circulation (2022)
Catheter ablation of atrial fibrillation was economically attractive compared with drug therapy in the CABANA Trial overall at present benchmarks for health care value in the United States on the basis of projected incremental QALYs but not LYs alone.